Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Nissan Chemical Corporation    4021   JP3670800006

NISSAN CHEMICAL CORPORATION

(4021)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
5910 5990 6010 5930 6120 Last
361100 338300 311800 229200 337900 Volume
+2.25% +1.35% +0.33% -1.33% +3.20% Change
Financials
Sales 2021 210 B 2 025 M 2 025 M
Net income 2021 31 683 M 305 M 305 M
Net cash position 2021 34 800 M 335 M 335 M
P/E ratio 2021 27,6x
Yield 2021 1,61%
Sales 2022 219 B 2 111 M 2 111 M
Net income 2022 33 750 M 325 M 325 M
Net cash position 2022 36 850 M 355 M 355 M
P/E ratio 2022 25,8x
Yield 2022 1,74%
Capitalization 882 B 8 499 M 8 497 M
EV / Sales 2021 4,03x
EV / Sales 2022 3,86x
Nbr of Employees 2 640
Free-Float 89,0%
More Financials
Company
Nissan Chemical Corporation specializes in manufacturing and marketing chemical products. Net sales break down by family of products as follows: - agrochemical products (28.4%): insecticides (Sanmite, Starmite, Mito-Kohne, Leimay and Ikaruga brands), herbicides (Roundup, Targa, Sirius and Permit), fertilizers, etc.; - coating materials (28%): polyimide resins, colloids, silicas, inorganic materials, etc. for the... 
More about the company
Notations Surperformance© of Nissan Chemical Corporation
Trading Rating : Investor Rating :
More Ratings
All news about NISSAN CHEMICAL CORPORATION
2020Chugai Files Patent Infringement Lawsuit concerning Edirol Capsules
AQ
2020Chugai Pharmaceutical Files Patent Infringement Lawsuit Against Nissan Chemic..
MT
2020NISSAN CHEMICAL CORPORATION : Half-year results
CO
2020NISSAN CHEMICAL CORPORATION : Press Release
CO
2020NISSAN CHEMICAL CORPORATION : half-yearly earnings release
2020NISSAN CHEMICAL CORPORATION : Ex-dividend day for interim dividend
FA
2020Nikkei inches higher; worries over PM Abe's health weigh
RE
2020Japanese shares edge higher, concerns over PM Abe's health weigh
RE
2020NISSAN CHEMICAL CORPORATION : Press Release
CO
2020NISSAN CHEMICAL CORPORATION : 1st quarter results
CO
2020NISSAN CHEMICAL CORPORATION : quaterly earnings release
2020Renault to take 3.6 billion euro hit from Nissan losses
RE
2020NISSAN CHEMICAL CORPORATION : Annual results
CO
2020NISSAN CHEMICAL CORPORATION : Slide show results
CO
2020NISSAN CHEMICAL CORPORATION : annual earnings release
More news
News in other languages on NISSAN CHEMICAL CORPORATION
2020NISSAN CHEMICAL CORPORATION : Veröffentlichung des Halbjahresergebnisses
2020NISSAN CHEMICAL CORPORATION : publication des résultats semestriels
2020Borsa Tokyo in lieve rialzo, frenata da timori su salute premier Abe
2020NISSAN CHEMICAL CORPORATION : publication des résultats trimestriels
2020NISSAN CHEMICAL CORPORATION : Veröffentlichung des Quartalsergebnisses
More news
Chart NISSAN CHEMICAL CORPORATION
Duration : Period :
Nissan Chemical Corporation Technical Analysis Chart | 4021 | JP3670800006 | MarketScreener
Technical analysis trends NISSAN CHEMICAL CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 6 178,89 JPY
Last Close Price 6 120,00 JPY
Spread / Highest target 16,0%
Spread / Average Target 0,96%
Spread / Lowest Target -22,1%
EPS Revisions
Managers and Directors
NameTitle
Kojiro Kinoshita President & Representative Director
Junichi Miyazaki CFO, Director, Executive Vice President
Katsuaki Miyaji Director & Manager-Public Relations
Hitoshi Suzuki Director, Managing Executive Officer & GM-Planning
Tadashi Ohe Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
NISSAN CHEMICAL CORPORATION-5.26%8 236
SHIN-ETSU CHEMICAL CO., LTD.7.10%77 294
BASF SE2.41%74 104
DUPONT DE NEMOURS, INC.14.03%59 533
ROYAL DSM N.V.4.40%30 344
ASAHI KASEI CORPORATION8.53%15 300